Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV) (HD2000)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Modena, Italy, 41100
- Centro Oncologico Modenese
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Histologically confirmed diagnosis of Hodgkin disease
- Clinical stage IIB, III, IV
- No prior treatment for Hodgkin disease or other malignancy
- Age 18-65 year
- Good cardiac, pulmunar, renal and hepatic function
- Performance status 0-3 (Karnofsky 100- 40)
- Written Informed Consent
Exclusion Criteria:
- HIV positivity
- Large cell, anaplastic, CD30+ lymphoma
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: abvd
|
|
|
Experimental: beacopp
|
|
|
Experimental: coppebvcad
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
|---|
|
To compare the toxicity of the COPPEBVCAD vs BEACOPP vs ABVD regimens
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
|---|
|
To compare the results in terms of response, failure free survival and relapse free survival of the three regimens
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Paolo Gobbi, MD, GISL
- Principal Investigator: Emilio Iannitto, MD, GISL
- Principal Investigator: Giuseppe Polimeno, MD, GISL
Study record dates
Study Major Dates
Study Start
Study Start
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- HD2000
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.